Skip to main content
. 2014 Jan 22;37(5):285–292. doi: 10.1002/clc.22246

Table 2.

Patient Demographic and Hospital Presentation Data

No Revascularization, n = 6999 Revascularization, n = 89 000 P Value
Patient demographics, %
Age, ya 77 (64, 85) 66 (55, 78) <0.0001
Male sex 48.0 60.5 <0.0001
Race
White 57.5 74.7 <0.0001
Black 8.1 8.3
Hispanic 9.7 7.5
Other 15.1 2.9
CAD 24.2 17.0 <0.0001
Prior MI 24.4 21.2 <0.0001
Prior CABG 2.8 2.4 0.0375
Prior PCI 1.7 3.7 <0.0001
DM 37.1 32.0 <0.0001
Smoking 18.6 29.5 <0.0001
Hyperlipidemia 36.8 46.0 <0.0001
Hypertension 70.6 68.0 <0.0001
PVD 10.3 8.7 <0.0001
Prior stroke 13.1 9.0 <0.0001
HF 28.5 14.1 <0.0001
COPD or asthma 19.2 13.3 <0.0001
Renal insufficiency 16.6 9.0 <0.0001
BMI ≥30 kg/m2 20.9 30.3 <0.0001
Payment source, %
Medicare 41.9 28.4 <0.0001
Medicaid 13.8 6.2
Other 32.2 42.7
Uninsured 4.7 9.0
Presentation data
SBP, mm Hga 135 (115, 156) 138 (119, 158) <0.0001
DBP, mm Hga 74 (62, 87) 77 (65, 90) <0.0001
Total cholesterol, mg/dLa 159 (130, 194) 167 (138, 199) <0.0001
LDL, mg/dLa 92 (68, 119) 99 (75, 127) <0.0001
Triglycerides, mg/dLa 109 (77, 158) 122 (84, 182) <0.0001
HbA1c, %a 7.1 (6.3, 8.2) 7.3 (6.4, 8.8) 0.0088
Hospital facilities
Academic, % 51.0 60.9 <0.0001
No. of bedsa 203 (101, 279) 367 (265, 530) <0.0001
Hospital location, %
Urban 57.7 95.0 <0.0001
Rural 42.3 5.0
Hospital region, %
West 32.9 25.9 <0.0001
South 28.0 31.2
Midwest 5.6 28.1
Northeast 33.5 14.8
Medications on admission, %
None 1.3 2.0 <0.0001
ASA 19.6 14.5 0.3403
β‐Blocker 9.9 6.2 <0.0001
ACEI 14.0 9.9 0.0150
ARB 6.5 4.0 <0.0001
Other antiplateletb 7.7 5.7 0.4665
CCB 6.6 4.7 0.2113
Nitrates 5.1 2.5 <0.0001
Statins 17.2 13.5 0.0747

Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ASA, aspirin; BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CCB, calcium channel blocker; CI, confidence interval; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HF, heart failure; LDL, low‐density lipoprotein cholesterol; MI, myocardial infarction; OR, odds ratio; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; SBP, systolic blood pressure; TIA, transient ischemic attack.

a

Continuous variables are expressed as median (25th, 75th percentile). b Excluding ASA.